Medical devices

inPROBE – disruptive platform technology with global potential to challenge the paradigm of targeted biology diagnostics and real-time targeted drugs delivery monitoring

Nowadays millions of people die each year from cancer. It’s a medical professionals to save lives of patients worldwide.At the same time the future of cancer therapies is here now, several targeted or gene therapies are gaining trust, but their efficiency is strictly depends on proper and real time targeted tumor biology diagnostics, which doeas not exist yet. That’s why we’ve invented and developed inPROBE, a platform technology which links targeted therapies with targeted diagnostics.Our technology will reduce diagnosis time, increase precision and improve the effects of innovative cancer treatments. It can be used both in cancer diagnostics and therapies monitoring in real time and in a natural state, thus giving medical professionals a previously unavailable fast and efficient tool.

  • Examination will take almost 15 minutes
  • Numerous results are printed in real time
  • Clear screen presents precise results

Key benefits

How it works

inPROBEis a nano-size glass probe placed in vivo inside a very thin biopsy needle, connected to a detecting device and with innovative components on a probe tip. Thanks to it’s thickness it is safer, much less stressful and much less painful.Fast and precise cancer diagnosis combined with modern therapies can help to SAVE UP TO 30% of people diagnosed with cancer by 2030.The high sensitivity of inProbe enables it into examine even single cells. It also allows to close access to the tumor without the need to get into the tumor as today, which can lead to malignant cancer.

  • USG examination before using inPROBE
  • inPROBE doesn’t need to touch tumor
  • Numerical results

All the data gathered during the procedure is transferred via fiber optics into the multi- purpose detecting device. The data is then calculated using specific algorithms and presented to the oncologist as a diagnostic result – a numerical measurement with exact level of tested components (e.g. HER2 cancer biomarker).

During cancer therapies inProbe will be able to measure the level of active ingredients (e.g. Trastuzumab) in cancer tumor cells, thus supporting & improving the efficiency of modern targeted cancer therapies and patients’ well-being.

Testimonials

SDS-MicroProbe can be a groundbreaking solution to overcome problems in current technology and enable analysis of biological processes inside the single cell in their natural state. As an expert in hematology, I am convinced that such solution would find several applications in research as well as in future cell therapies in the cancer area.

Hematologist/Oncologist M.D. PhD
with several years of scientific experience at NIH
Bethesda, MD, USA

There is an unmet need to study biological processes within individual cells residing in their native niche. The SDS-MicroProbe addresses this shortcoming; it is a new approach in analyzing key intracellular parameters that indicate the functionality of a cell. The SDS-MicroProbe has the potential to substantially advance our ability to assess the status of living cells and thereby improve our ability to diagnose various diseases and evaluate the efficiency of interventions.

Professor, PhD of Harvard Medical School
Boston, MA, USA

Brochure

If you want to know more about our project, you can download the newest brochure here or visit our website www.inprobe.com